Stay updated on market trends for SGRY. Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session Avi Kapoor Harmonic ...

Healthcare company Surgery Partners (NASDAQ:SGRY) will be announcing earnings results tomorrow before market open. Here’s ...

Surgery Partners SGRY shares soared 21.2% in the last trading session to close at $25.75. The move was backed by solid volume with far more shares changing hands than in a normal session.

Surgery Partners (SGRY) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.44 per share a year ago.

In a report released yesterday, Ben Hendrix from RBC Capital maintained a Buy rating on Surgery Partners (SGRY – Research Report), with a price ...

Healthcare company Surgery Partners (NASDAQ:SGRY) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 17.5% year on year to $864.4 million. The company expects the full year’s ...

Surgery Partners (NASDAQ:SGRY – Get Free Report)‘s stock had its “outperform” rating restated by stock analysts at Royal Bank of Canada in a research report issued on Tuesday,Benzinga reports. They ...

SURGERY PARTNERS ($SGRY) posted quarterly earnings results on Monday, March 3rd. The company reported earnings of $0.44 per share, beating estimates of $0.38 by $0.06 ...

In a report released today, Ben Hendrix from RBC Capital reiterated a Buy rating on Surgery Partners (SGRY – Research Report), with a price target of $35.00. The company’s shares closed last ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Detailed price information for Surgery Partners CS (SGRY-Q) from The Globe and Mail including charting and trades.